Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 5Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other 5

Conditions

Opioid-Induced Constipation 5

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × INDUSTRY × naloxegol × Clear all
NCT03638440 2024-06-17

NACASY

Kyowa Kirin Co., Ltd.

Completed
183 enrolled
Other

Opioid-Induced Constipation

NCT01395524 2017-02-23

A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
302 enrolled 13 charts
Other

Opioid-Induced Constipation

NCT01323790 2015-06-02

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
700 enrolled 25 charts
Other

Opioid-Induced Constipation

NCT01309841 2015-06-01

Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
652 enrolled 25 charts
Other

Opioid-Induced Constipation

NCT01336205 2014-10-20

Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation

AstraZeneca

Phase 3 Completed
844 enrolled 10 charts
Other

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡